Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SIRPL (Stowarzyszenie Importerów Równoległych Produktów Leczniczych) is the leading Polish industry association representing parallel importers of medicinal products. Established in 2006, the organization advocates for the legal and safe distribution of original pharmaceutical products imported from other European Economic Area (EEA) countries to the Polish market. SIRPL plays a critical role in the Polish healthcare system by promoting competition, which significantly reduces drug costs for patients and the national health budget. The association is a key member of the European Association of Euro-Pharmaceutical Companies (EAEPC) and was a founding member of the Polish Medicines Verification Organisation (KOWAL), which implemented the Falsified Medicines Directive (FMD) in Poland.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SIRPL.